Aldeyra Therapeutics, Inc. (ALDX)
1.645
-0.02
(-0.90%)
USD |
NASDAQ |
May 15, 13:22
Aldeyra Therapeutics Shareholders Equity (Quarterly) : 42.16M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Rhythm Pharmaceuticals, Inc. | 122.91M |
| AbbVie, Inc. | -6.656B |
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| ADMA Biologics, Inc. | 390.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 66.48M |
| Total Liabilities (Quarterly) | 24.33M |
| Debt to Equity Ratio | 0.368 |
| Current Ratio | 2.688 |
| Net Debt Paydown Yield | -0.04% |